---
title: Why Optimal DX Focuses on Functional (Not Pathology-Based) Blood Biomarkers
description: Discover why Optimal DX focuses on functional blood biomarkers for early detection and prevention rather than pathology-based tests for diagnosing serious diseases. Learn about the benefits of Functional Blood Chemistry Analysis.
---

[The Optimal DX Research Blog ](https://www.optimaldx.com/research-blog)

# [Why Optimal DX Focuses on Functional (Not Pathology-Based) Blood Biomarkers](https://www.optimaldx.com/research-blog/why-optimal-dx-focuses-on-functional-not-pathology-based-blood-biomarkers)

 Written by [Dr. Dicken Weatherby](https://www.optimaldx.com/research-blog/author/dr-dicken-weatherby) | Feb 5, 2025 10:35:22 PM

At **Optimal DX**, our mission is to provide **cutting-edge Functional Blood Chemistry Analysis (FBCA)** to help practitioners optimize patient health through **early detection of functional imbalances and preventive care**.

We are frequently asked why certain **specialized, pathology-based tests**—like advanced tumor markers, comprehensive autoimmune panels, heavy metals screenings, or infectious-disease profiles—are **not** included in our standard software.

Although these tests are vital in diagnosing **specific diseases** or **severe toxicities**, **they lie outside the core objectives of FBCA**, which is all about detecting **subclinical imbalances** and optimizing health *before* disease manifests.

Below, we’ll explain how **functional** and **pathology-based** markers differ, and why **Optimal DX** continues to emphasize **prevention, early intervention, and holistic insights** over specialized diagnostics for confirmed or suspected pathology.

## **Pathology vs. Functional Health: Understanding the Difference**

### **1. Pathology Markers Zero In on Known or Suspected Diseases**

Pathology-based tests aim to **diagnose or rule out** specific conditions. They are critical when a patient—or their healthcare provider—already suspects a serious, often **life-altering** disorder that may require aggressive interventions.

Here are some examples commonly requested by practitioners:

**Autoimmune Profiles**

- **Vasculitis Profile (RDL), ANCA Profile (RDL), Autoimmune Liver Profile (RDL), IBD Expanded Panel, IBD Profile (RDL)**, **Celiac Disease Comprehensive**
- **Purpose: **Identify autoimmune processes (e.g., vasculitis, inflammatory bowel disease, autoimmune liver disease, celiac disease).
- **Significance:** Positive results require further specialty consultation and potential immunosuppressive treatments or advanced dietary protocols.

**Infectious-Disease Testing**

- **Lyme, Line Blot (Serum)**, **M005-IgG Candida albicans**
- **Purpose:** Confirm active or chronic infections.
- **Significance:** Points to a **disease-state** requiring targeted antimicrobial or antifungal therapy.

**Tumor Markers**

- **CEA, AFP, CA 19-9, CA 125**
- **Purpose:** Monitor known malignancies or investigate potential cancer in at-risk individuals.
- **Significance:** Abnormal results often necessitate **oncologic evaluations, biopsies, or imaging**.

**Heavy Metals Profile, Blood**

- **Purpose**: Identify toxic exposures to metals like lead, mercury, arsenic.
- Significance: High levels indicate **potential toxicity** that might require chelation therapy or public health intervention.

**ILDdx Profile (RDL)**

- Purpose: Evaluate potential **interstitial lung diseases**.
- Significance: Helps specialists confirm or manage complex pulmonary conditions.

**Immunofixation & Immunoglobulins**

- **IFE, PE and FLC, Serum**, **Immunoglobulins A/E/G/M**
- **Purpose:** Assess for conditions like **multiple myeloma**, **monoclonal gammopathy**, or **immune deficiencies**.
- Significance: Abnormal patterns warrant **hematologic or oncologic follow-up**.

**In short,** these tests are designed to uncover **serious pathologies**, confirm disease progression, or guide specialized treatments. They’re not part of a **preventive or subclinical** approach; rather, they’re about diagnosing or managing *known or suspected* disease.

### **2. Functional Blood Chemistry Focuses on Prevention & Optimization**

**Functional Blood Chemistry Analysis** zeros in on detecting **imbalances** and **suboptimal physiology** before a disease is labeled. By examining **optimal rather than conventional reference ranges**, FBCA helps practitioners catch issues—like **insulin resistance, low-grade inflammation, mild nutrient deficiencies, and early hormonal dysregulation**—that often slip under the radar of standard, disease-focused labs.

- **Common Functional Markers**: 
    - **Glucose, Hemoglobin A1c, Insulin** for metabolic health and prediabetes.
    - **Lipid profiles** (HDL, LDL, Triglycerides) to evaluate cardiovascular risk from a **functional** standpoint.
    - **CBC with differential** to identify **immunological and inflammatory trends**.
    - **Liver, kidney, and thyroid panels** that alert practitioners to **suboptimal organ function**.

The **goal**: equip clinicians with insights that allow for **timely intervention** using nutrition, lifestyle modifications, and **targeted supplementation**—ideally preventing full-blown pathology.

## **Why Optimal DX Excludes These Pathology-Based Markers**

1. **Focused Mission**: **Optimal DX** is built to **spot functional imbalances** and **early risk factors**. We leave advanced disease diagnostics—like tumor marker analysis, comprehensive autoimmune screening, or heavy metal quantification—to specialty labs and practitioners who suspect **serious underlying conditions**.
2. **Preventive & Holistic Approach**: Our **FBCA platform** seamlessly supports **dietary, lifestyle, and supplemental interventions**. In contrast, pathology-based markers often prompt **surgical, oncologic, or immunosuppressant** therapies—beyond the scope of typical functional medicine **early-stage interventions**.
3. **Clear Clinical Pathways**: If you, as a practitioner, see evidence from a Functional Blood Chemistry panel suggesting an advanced disease or toxicity, you would **add these specialized tests separately** or **refer** your patient to the appropriate **specialist**. This ensures the **best standard of care** without conflating functional screening with disease-specific diagnostics.
4. **Actionable Insights for Optimization**: By limiting our panels to **standard chemistry markers** and other function-focused tests, we provide **immediately actionable data** that helps practitioners refine **wellness protocols**—not disease management plans.

## **What About Markers Like NRBC, Bands, Metamyelocytes, Myelocytes, etc.?**

In addition to the profiles listed above, **bone marrow–oriented cells** sometimes appear on lab reports:

- **Nucleated Red Blood Cells (NRBC, %)**
- **Bands, Metamyelocytes, Myelocytes (%)**
- **Megakaryocytes (%)**
- **Other, Lineage Uncertain (%)**

**Why aren’t these included in a functional panel?** Because the presence of these **immature or atypical blood cells** typically indicates **active bone marrow pathology**, severe infection, or **blood-related malignancies**—areas that require **urgent, specialized care** and are beyond the scope of **Functional Blood Chemistry Analysis**.

## **Are Pathology-Based Tests Ever Useful in Functional Care?**

Absolutely. In some cases, a patient’s **functional results** or clinical symptoms might suggest an **autoimmune disease, malignancy, heavy metal toxicity, or chronic infection**. When that suspicion arises, **ordering the relevant specialized panel** or **referring to a specialist** is the *correct* next step.

However, these diagnostics are not part of **routine functional screening** because they’re **not intended for optimizing health** so much as **detecting and managing disease** once it’s on the table.

## **Conclusion: The Power of a Focused Functional Approach**

At **Optimal DX**, our mission is to **identify subclinical dysfunction** and guide practitioners toward early, **preventive interventions**. While we respect and acknowledge the importance of **pathology-based tests**, we believe keeping them separate from our standard FBCA panels helps clinicians better **target root causes, promote holistic well-being, and optimize patient outcomes** *before* acute disease sets in.

For practitioners looking to enhance their approach to **blood test analysis, functional assessments, and personalized treatment planning**, Optimal DX offers a **comprehensive, data-driven platform** to support your practice.

### **Take the Next Step Toward Functional Optimization**

Curious about how **Optimal DX** can enhance your practice and transform patient health through **Functional Blood Chemistry Analysis**? Check out  [**OptimalDX.com**](https://www.optimaldx.com/research-blog/why-optimal-dx-focuses-on-functional-not-pathology-based-blood-biomarkers?hs_amp=true#) or [contact us](https://www.optimaldx.com/contact) directly to see how our platform can help you **spot trends early**, address **underlying imbalances**, and **prevent** severe health issues down the road.

Want to learn more about the biomarkers we do have in Optimal DX? Check out our [Ultimate Biomarker Guide today!](https://www.optimaldx.com/odx-blood-biomarker-guide)

** **

[View full post](https://www.optimaldx.com/research-blog/why-optimal-dx-focuses-on-functional-not-pathology-based-blood-biomarkers)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Dr. Dicken Weatherby"
  },
  "dateModified" : "2025-03-14T18:29:32.997Z",
  "datePublished" : "2025-02-05T22:35:22Z",
  "headline" : "Why Optimal DX Focuses on Functional (Not Pathology-Based) Blood Biomarkers",
  "image" : {
    "@type" : "ImageObject",
    "height" : 648,
    "url" : "https://5340373.fs1.hubspotusercontent-na1.net/hubfs/5340373/blog_graphics/Site%20Blog%20Placeholder%20Images_E1.png",
    "width" : 1153
  },
  "mainEntityOfPage" : "https://www.optimaldx.com/research-blog/why-optimal-dx-focuses-on-functional-not-pathology-based-blood-biomarkers",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "The Optimal DX Research Blog"
  }
}
```